Selected Publications
Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Jain SK, Bivalacqua TJ, Yegnasubramanian S, Bishai WR: Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation bioRxiv : 2022 (Epub).
Harris TGW, Khandge P, Wu WJ, Leto Barone AA, Manyevitch R, Sholklapper T, Bivalacqua TJ, Burnett AL, Redett RJ 3rd, Gearhart JP: Sexual health outcomes after penile reconstruction in the exstrophy-epispadias complex Journal of Pediatric Urology : 2022 (Epub).
Einerhand SMH, Black AJ, Zargar H, Fairey AS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobson NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Kassouf W, Dall'Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Garcia JA, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, van Rhijn BWG, Black PC, Mertens LS: Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer World Journal of Urology 40 (11): 2707-2715,2022.
Alam R, Patel SH, Kates MR, Singla N, Pavlovich CP, Allaf ME, Bivalacqua TJ, Pierorazio PM: Differential changes in self-reported quality of life in elderly populations after diagnosis of a genitourinary malignancy Urologic Oncology 40 (10): 455.e1-455.e10,2022.
Tan WS, Steinberg G, Witjes JA, Li R, Shariat SF, Roupret M, Babjuk M, Bivalacqua TJ, Psutka SP, Williams SB, Cookson MS, Palou J, Kamat AM: Intermediate-risk non-muscle-invasive bladder cancer: Updated consensus definition and management recommendations from the International Bladder Cancer Group European Urology Oncology 5 (5): 505-516,2022.
Gupta N, Patel HD, Taylor J, Borin JF, Jacobsohn K, Kenfield SA, Eggener SE, Price C, Davuluri M, Byrne N, Bivalacqua TJ, Loeb S: Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes Prostate Cancer & Prostatic Diseases 25 (3): 444-452,2022.
Pohar KS, Patel S, Lotan Y, Trabulsi E, Woods M, Downs T, Huang WC, Jones J, Taylor J, O'Donnell M, Bivalacqua TJ, DeCastro J, Steinberg G, Kamat AM, Resnick MJ, Konety B, Schoenberg M, Jones JS, Daneshmand S; Flexible Blue Light Study Group Collaborators: Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center study Urologic Oncology 40 (8): 382.e1-382.e6,2022.
Sharma S, Rajani S, Hui J, Chen A, Bivalacqua T, Singh A: Development of enzymatic-resistant and compliant decellularized extracellular matrixes via aliphatic chain modification for bladder tissue engineering ACS Applied Materials & Interfaces 14 (33): 37301-37315,2022.
Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE Jr: The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: An AUA/SMSNA Guideline Journal of Urology 208 (1): 43-52,2022.
Roumiguié M, Kamat AM, Bivalacqua TJ, Lerner SP, Kassouf W, Böhle A, Brausi M, Buckley R, Persad R, Colombel M, Lamm D, Palou-Redorta J, Soloway M, Brothers K, Steinberg G, Lotan Y, Sylvester R, Alfred Witjes J, Black PC: International Bladder Cancer Group Consensus Statement on clinical trial design for patients with bacillus Calmette-Guérin-exposed high-risk non-muscle-invasive bladder cancer European Urology 82 (1): 34-46,2022.
Academic Contact Information
Division of Urology
Hospital of the University of Pennsylvania
3400 Spruce St. 3d Fl. W. Perelman Center
Philadelphia,
PA
19104
Phone: 215-301-9341
Patient appointments: 800-789-7366